Transcranial magnetic stimulation (TMS) therapy is an advanced treatment that has transformed the lives of many individuals with mental health conditions. Despite its proven benefits and increasing adoption, numerous misconceptions about TMS persist. These misunderstandings may prevent patients from exploring this potentially life-changing therapy. Addressing misconceptions about TMS is essential for empowering patients to make informed decisions about their mental health care.
A widespread misbelief about TMS therapy is that it is a painful procedure. This belief likely stems from the idea that stimulating the brain might involve invasive techniques. In reality, NeuroStar TMS therapy is non-invasive and painless. It does not require the use of needles, anesthesia, or sedation. During treatment sessions, magnetic pulses are delivered to targeted areas of the brain via a coil placed on the scalp. Although some patients experience mild sensations, such as tapping or tingling at the treatment site, these effects are generally temporary and well-tolerated. This mild discomfort should not discourage patients from considering NeuroStar TMS as an option.
Another common myth is that TMS therapy is only effective for treating depression. While TMS was initially approved by the Food and Drug Administration (FDA) for the treatment of major depressive disorder, its therapeutic applications have expanded significantly over the years. Research and clinical practice have demonstrated that TMS can also benefit individuals suffering from anxious depression, obsessive-compulsive disorder, and even chronic pain conditions. Patients with a variety of mental health challenges may find relief through NeuroStar TMS therapy, depending on their specific diagnosis and treatment plan.
TMS misconceptions also involve concerns that the therapy could cause brain damage—these are unfounded and based on misinformation. NeuroStar TMS therapy operates by using magnetic pulses to stimulate targeted brain regions associated with mood regulation and other functions. Unlike invasive procedures, NeuroStar TMS does not alter the structure of the brain or cause long-term harm. Extensive research supports its safety profile, with minimal and short-lived side effects reported. For example, patients may occasionally experience mild headaches or scalp discomfort following a session, but these side effects typically resolve quickly. Serious complications, such as seizures, are extremely rare and occur at rates comparable to other well-established medical treatments.
Another mistaken belief is that TMS therapy is experimental or unproven. TMS has been FDA-approved since 2008 for the treatment of major depressive disorder and has undergone rigorous testing to establish its safety and efficacy. Over the years, numerous clinical trials and scientific studies have reinforced its reputation as a reliable and evidence-based therapeutic option. As more practitioners incorporate NeuroStar TMS into their practices, its use has become increasingly standardized and accessible, further dispelling any doubts about its legitimacy as a mainstream treatment.
Some individuals mistakenly believe that TMS therapy is designed to replace traditional treatments, such as medication or psychotherapy. In reality, NeuroStar TMS is often used as an adjunct approach that enhances the effectiveness of these treatments. It is particularly beneficial for patients who have not experienced significant improvement with conventional methods alone. For some, TMS serves as an alternative when medication or therapy is not well-tolerated due to side effects or personal preferences. By working in conjunction with other treatments, NeuroStar TMS provides a holistic approach to managing mental health conditions and improving overall well-being.
Addressing misconceptions about TMS is critical for patients who may feel hesitant about exploring this therapy. NeuroStar TMS offers a non-invasive, safe, and effective treatment option for a range of mental health conditions, making it a valuable addition to modern therapeutic practices. By addressing myths surrounding TMS, patients can approach their mental health journey with confidence and an open mind.
For those seeking more information about TMS therapy, contacting a qualified provider is an important first step. Call our team today and schedule a consultation so we can help you make an informed decision about incorporating NeuroStar TMS into your mental health care plan and move toward improved well-being.
Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
NeuroStar Advanced Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar Advanced Therapy has not been studied in patients who have not received prior antidepressant treatment.
